<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from the Statements of Operations and Balance Sheets of InVitro International and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000872610 <NAME> INVITRO INTERNATIONAL <MULTIPLIER> 1000 <FISCAL-YEAR-END> Sep-30-1997 <PERIOD-START> Oct-01-1996 <PERIOD-END> Dec-31-1996 <PERIOD-TYPE> 3-MOS <CASH> 859 <SECURITIES> 0 <RECEIVABLES> 203 <ALLOWANCES> 15 <INVENTORY> 510 <CURRENT-ASSETS> 1,594 <PP&E> 1,049 <DEPRECIATION> 846 <TOTAL-ASSETS> 1,954 <CURRENT-LIABILITIES> 399 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 25,036 <OTHER-SE> (23,481) <TOTAL-LIABILITY-AND-EQUITY> 1,954 <SALES> 259 <TOTAL-REVENUES> 259 <CGS> 184 <TOTAL-COSTS> 779 <OTHER-EXPENSES> (14) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (506) <INCOME-TAX> 0 <INCOME-CONTINUING> (506) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (506) <EPS-PRIMARY> (.04) <EPS-DILUTED> (.04)